New diagnostic criteria and PVR thresholds in SSc-associated PH: Insights from the ASPIRE registry
A. Haque (Sheffield (South Yorkshire), United Kingdom), A. Charalampopoulos (Sheffield (South Yorkshire), United Kingdom), K. Dwivedi (Sheffield (South Yorkshire), United Kingdom), C. Elliot (Sheffield (South Yorkshire), United Kingdom), A. Hameed (Sheffield (South Yorkshire), United Kingdom), N. Hamilton (Sheffield (South Yorkshire), United Kingdom), R. Lewis (Sheffield (South Yorkshire), United Kingdom), S. Ramjug (Sheffield (South Yorkshire), United Kingdom), A. Rothman (Sheffield (South Yorkshire), United Kingdom), R. Thompson (Sheffield (South Yorkshire), United Kingdom), A. Swift (Sheffield (South Yorkshire), United Kingdom), D. Kiely (Sheffield (South Yorkshire), United Kingdom), R. Condliffe (Sheffield (South Yorkshire), United Kingdom)
Source: International Congress 2022 – Novelties in pulmonary hypertension management
Session: Novelties in pulmonary hypertension management
Session type: Oral Presentation
Number: 2277
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Haque (Sheffield (South Yorkshire), United Kingdom), A. Charalampopoulos (Sheffield (South Yorkshire), United Kingdom), K. Dwivedi (Sheffield (South Yorkshire), United Kingdom), C. Elliot (Sheffield (South Yorkshire), United Kingdom), A. Hameed (Sheffield (South Yorkshire), United Kingdom), N. Hamilton (Sheffield (South Yorkshire), United Kingdom), R. Lewis (Sheffield (South Yorkshire), United Kingdom), S. Ramjug (Sheffield (South Yorkshire), United Kingdom), A. Rothman (Sheffield (South Yorkshire), United Kingdom), R. Thompson (Sheffield (South Yorkshire), United Kingdom), A. Swift (Sheffield (South Yorkshire), United Kingdom), D. Kiely (Sheffield (South Yorkshire), United Kingdom), R. Condliffe (Sheffield (South Yorkshire), United Kingdom). New diagnostic criteria and PVR thresholds in SSc-associated PH: Insights from the ASPIRE registry. 2277
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|